Vimarsana
Biggest News Aggregation in the World

Page 2 - Presentations Include News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Presentations Include. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Presentations Include Today - Breaking & Trending Today

Biogen Inc.: New Data Presented at Cure SMA Reveal Residual Unmet Needs in Young SMA Patients Treated With Gene Therapy and Suggest Further Potential of Using SPINRAZA (nusinersen) - Vimarsana News

Biogen Inc.: New Data Presented at Cure SMA Reveal Residual Unmet Needs in Young SMA Patients Treated With Gene Therapy and Suggest Further Potential of Using SPINRAZA (nusinersen)

RESPOND study is actively enrolling, with baseline characteristics reporting infants and toddlers have residual unmet medical needs in multiple areas after gene therapy; SPINRAZA treatment following gene

DCISionRT® Demonstrates 40 Percent Change in Radiation Therapy Treatment Recommendation for DCIS Patients - Vimarsana News

DCISionRT® Demonstrates 40 Percent Change in Radiation Therapy Treatment Recommendation for DCIS Patients

/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today it...

DCISionRT® Demonstrates 40 Percent Change in Radiation Therapy Treatment Recommendation for DCIS Patients - Vimarsana News

DCISionRT® Demonstrates 40 Percent Change in Radiation Therapy Treatment Recommendation for DCIS Patients

/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today it...

Biogen Inc.: New Data at Cure SMA 2021 Highlight the Long-Term Efficacy of SPINRAZA (nusinersen) and Biogen's Commitment to Innovation in SMA Therapy - Vimarsana News

Biogen Inc.: New Data at Cure SMA 2021 Highlight the Long-Term Efficacy of SPINRAZA (nusinersen) and Biogen's Commitment to Innovation in SMA Therapy

New data analysis suggests an investigational higher dose of SPINRAZA may lead to clinically meaningful improvements in motor functionA NURTURE study analysis shows 92 percent of children who initiated